1. Nanodisc technology facilitates identification of monoclonal antibodies targeting multi-pass membrane proteins
- Author
-
Christy Ann Thomson, Bernd Gardill, Lawrence Tu, Jerry Huang, Filip Van Petegem, and Kirill Oxenoid
- Subjects
Models, Molecular ,0301 basic medicine ,Scaffold protein ,Protein Conformation ,medicine.drug_class ,Recombinant Fusion Proteins ,Protein domain ,lcsh:Medicine ,Monoclonal antibody ,Article ,Flow cytometry ,Antigen-Antibody Reactions ,Mice ,03 medical and health sciences ,Drug Delivery Systems ,0302 clinical medicine ,Protein structure ,Bacterial Proteins ,Protein Domains ,Antibody Specificity ,medicine ,Animals ,lcsh:Science ,Nanodisc ,Arcobacter ,Hybridomas ,Multidisciplinary ,medicine.diagnostic_test ,Chemistry ,NAV1.7 Voltage-Gated Sodium Channel ,lcsh:R ,Antibodies, Monoclonal ,Membrane Proteins ,Flow Cytometry ,Nanostructures ,Cell biology ,030104 developmental biology ,Membrane ,Solubility ,Membrane protein ,Immunoglobulin G ,Ion channels ,lcsh:Q ,Antibody therapy ,030217 neurology & neurosurgery - Abstract
Multi-pass membrane proteins are important targets of biologic medicines. Given the inherent difficulties in working with membrane proteins, we sought to investigate the utility of membrane scaffold protein nanodiscs as a means of solubilizing membrane proteins to aid antibody discovery. Using a model multi-pass membrane protein, we demonstrate how incorporation of a multi-pass membrane protein into nanodiscs can be used in flow cytometry to identify antigen-specific hybridoma. The use of target protein-loaded nanodiscs to sort individual hybridoma early in the screening process can reduce the time required to identify antibodies against multi-pass membrane proteins.
- Published
- 2020
- Full Text
- View/download PDF